why choose us

First received: July 28, 2023

Clinical Trial: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Myositis

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Single-Arm, Multicenter, Open-label Extension of Study ARGX-113-2007 to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Participants Aged 18 Years an

Brief Summary: The purpose of this study is to measure the long-term safety and tolerability of efgartigimod PH20 SC in adult participants with IIM who previously participated in ARGX-113-2007.Secondary objectives include efficacy measures of efgartigimod PH20 SC in participants with IIM.

Read more